A review of connectivity map and computational approaches in pharmacogenomics

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Briefings Bioinform.

• Publication date

  2017-09-01

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.1093/bib/bbw112PMID 28069634PMCID PMC5952941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictive approaches for drug combination discovery in cancer

  2018cited by this paper
• Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy.

  2017cited by this paper
• Weakly supervised learning of biomedical information extraction from curated data

  2016cited by this paper
• L1000CDS2: LINCS L1000 characteristic direction signatures search engine

  2016cited by this paper
• Identification of associations between small molecule drugs and miRNAs based on functional similarity

  2016cited by this paper
• A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping

  2016cited by this paper
• Assessment of pharmacogenomic agreement

  2016cited by this paper
• Model-Based Clustering With Data Correction For Removing Artifacts In Gene Expression Data.

  2016cited by this paper
• Integrative pharmacogenomics to infer large-scale drug taxonomy

  2016cited by this paper
• Connectivity mapping (ssCMap) to predict A20-inducing drugs and their antiinflammatory action in cystic fibrosis

  2016cited by this paper
• Elucidation and Pharmacological Targeting of Novel Molecular Drivers of Follicular Lymphoma Progression.

  2016cited by this paper
• Connectivity Mapping (ssCMap) To Predict A20 Inducing Drugs: Anti-inflammatory Action In Cystic Fibrosis

  2016cited by this paper
• QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

  2016cited by this paper
• Transcriptional response networks for elucidating mechanisms of action of multitargeted agents.

  2016cited by this paper
• DT-Web: a web-based application for drug-target interaction and drug combination prediction through domain-tuned network-based inference

  2015cited by this paper
• Prioritizing Therapeutics for Lung Cancer: An Integrative Meta-analysis of Cancer Gene Signatures and Chemogenomic Data

  2015influential reference
• Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies

  2015cited by this paper
• Elucidating Compound Mechanism of Action by Network Perturbation Analysis.

  2015cited by this paper
• Reconstruction and analysis of a genome-scale metabolic model of the oleaginous fungus Mortierella alpina

  2015cited by this paper
• PharmacoGx: an R package for analysis of large pharmacogenomic datasets

  2015cited by this paper
• Public data and open source tools for multi-assay genomic investigation of disease

  2015cited by this paper
• Recovering Drug-Induced Apoptosis Subnetwork from Connectivity Map Data

  2015cited by this paper
• Mining drug–disease relationships as a complement to medical genetics‐based drug repositioning: Where a recommendation system meets genome‐wide association studies

  2015cited by this paper
• Developing a Molecular Roadmap of Drug-Food Interactions

  2015cited by this paper
• Perturbation biology nominates upstream–downstream drug combinations in RAF inhibitor resistant melanoma cells

  2015cited by this paper
• Systematic drug safety evaluation based on public genomic expression (Connectivity Map) data: myocardial and infectious adverse reactions as application cases.

  2015cited by this paper
• Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data

  2015cited by this paper
• Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products.

  2015cited by this paper
• Revisiting inconsistency in large pharmacogenomic studies

  2015cited by this paper
• Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis.

  2015cited by this paper
• Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL

  2014cited by this paper
• Identification of Differently Expressed Genes and Small Molecule Drugs for Tetralogy of Fallot by Bioinformatics Strategy

  2014cited by this paper
• Abstract 5371: Drug repositioning with a bioinformatics platform that integrates the TCGA, cMap and CCLE

  2014cited by this paper
• SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.

  2014cited by this paper
• Drug-repurposing identified the combination of Trolox C and Cytisine for the treatment of type 2 diabetes

  2014cited by this paper
• Systematic evaluation of connectivity map for disease indications

  2014influential reference
• DrugComboRanker: drug combination discovery based on target network analysis

  2014cited by this paper
• High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors

  2014cited by this paper
• Functional Module Connectivity Map (FMCM): A Framework for Searching Repurposed Drug Compounds for Systems Treatment of Cancer and an Application to Colorectal Adenocarcinoma

  2014cited by this paper
• LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures

  2014cited by this paper
• Large-scale integration of small molecule-induced genome-wide transcriptional responses, Kinome-wide binding affinities and cell-growth inhibition profiles reveal global trends characterizing systems-level drug action

  2014influential reference
• Targeted therapy in gastric cancer: personalizing cancer treatment based on patient genome.

  2014influential reference
• RNH1 regulation of reactive oxygen species contributes to histone deacetylase inhibitor resistance in gastric cancer cells

  2014cited by this paper
• Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells

  2014influential reference
• Discovery of the neuroprotective effects of alvespimycin by computational prioritization of potential anti‐parkinson agents

  2014cited by this paper
• Probabilistic drug connectivity mapping

  2014influential reference
• The characteristic direction: a geometrical approach to identify differentially expressed genes

  2014cited by this paper
• Assessing compound carcinogenicity in vitro using connectivity mapping.

  2014cited by this paper
• Transcriptional data: a new gateway to drug repositioning?

  2013cited by this paper
• Network based elucidation of drug response: from modulators to targets

  2013cited by this paper
• A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.

  2013cited by this paper
• cudaMap: a GPU accelerated program for gene expression connectivity mapping

  2013cited by this paper
• Identification of structural features in chemicals associated with cancer drug response: a systematic data-driven analysis

  2013cited by this paper
• BRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database

  2013cited by this paper
• RETRACTED ARTICLE: Protein–Protein Interaction Network Analysis in Chronic Obstructive Pulmonary Disease

  2013cited by this paper
• Drug repositioning: a machine-learning approach through data integration

  2013cited by this paper
• Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

  2013cited by this paper
• Predicting cancer drug mechanisms of action using molecular network signatures.

  2013cited by this paper
• Comparing gene expression similarity metrics for connectivity map

  2013cited by this paper
• K-Map: connecting kinases with therapeutics for drug repurposing and development

  2013cited by this paper
• Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data

  2013cited by this paper
• Target identification and mechanism of action in chemical biology and drug discovery.

  2013cited by this paper
• High-Throughput Methods for Combinatorial Drug Discovery

  2013cited by this paper
• Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders

  2013cited by this paper
• Entinostat Prevents Leukemia Maintenance in a Collaborating Oncogene‐Dependent Model of Cytogenetically Normal Acute Myeloid Leukemia

  2013cited by this paper
• Finding the targets of a drug by integration of gene expression data with a protein interaction network.

  2013cited by this paper
• Drug repurposing a reality: from computers to the clinic

  2013cited by this paper
• CDA: Combinatorial Drug Discovery Using Transcriptional Response Modules

  2012cited by this paper
• A chemical genetic approach identifies piperazine antipsychotics as promoters of CNS neurite growth on inhibitory substrates.

  2012cited by this paper
• Using Functional Signatures to Identify Repositioned Drugs for Breast, Myelogenous Leukemia and Prostate Cancer

  2012influential reference
• Disease-drug pairs revealed by computational genomic connectivity mapping on GBA1 deficient, Gaucher disease mice

  2012cited by this paper
• Evaluation of Analytical Methods for Connectivity Map Data

  2012influential reference
• Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer.

  2012cited by this paper
• DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data

  2012cited by this paper
• Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses

  2012cited by this paper
• NCBI GEO: archive for functional genomics data sets—update

  2012cited by this paper
• Querying Genomic Databases: Refining the Connectivity Map

  2012cited by this paper
• Applications of Connectivity Map in drug discovery and development.

  2012influential reference
• Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease

  2011cited by this paper
• mRNA Expression Signatures of Human Skeletal Muscle Atrophy Identify a Natural Compound that Increases Muscle Mass

  2011cited by this paper
• Discovery of Molecular Mechanisms of Traditional Chinese Medicinal Formula Si-Wu-Tang Using Gene Expression Microarray and Connectivity Map

  2011cited by this paper
• Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data

  2011cited by this paper
• Building the process-drug–side effect network to discover the relationship between biological Processes and side effects

  2011cited by this paper
• Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer

  2011cited by this paper
• Exploiting drug-disease relationships for computational drug repositioning

  2011cited by this paper
• Expression-Based In Silico Screening of Candidate Therapeutic Compounds for Lung Adenocarcinoma

  2011cited by this paper
• A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway in ovarian cancer cells.

  2011cited by this paper
• Bayesian approach to transforming public gene expression repositories into disease diagnosis databases

  2010cited by this paper
• Drug-Induced Regulation of Target Expression

  2010influential reference
• Drug Discovery in a Multidimensional World: Systems, Patterns, and Networks

  2010cited by this paper
• Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.

  2010cited by this paper
• CancerResource: a comprehensive database of cancer-relevant proteins and compound interactions supported by experimental knowledge

  2010cited by this paper
• Identification of novel hair‐growth inducers by means of connectivity mapping

  2010cited by this paper
• Discovery of drug mode of action and drug repositioning from transcriptional responses

  2010cited by this paper
• sscMap: An extensible Java application for connecting small-molecule drugs using gene-expression signatures

  2009cited by this paper
• Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.

  2008cited by this paper
• Gene expression module-based chemical function similarity search

  2008cited by this paper
• A simple and robust method for connecting small-molecule drugs using gene-expression signatures

  2008influential reference
• Determination of tag density required for digital transcriptome analysis: Application to an androgen-sensitive prostate cancer model

  2008cited by this paper
• Proteomic and transcriptomic study on the action of a cytotoxic saponin (Polyphyllin D): Induction of endoplasmic reticulum stress and mitochondria‐mediated apoptotic pathways

  2008cited by this paper

• In Silico Analysis of Squamous Cell Carcinoma.

  2026cites this paper
• Modulating metabolic signatures to mitigate cabozantinib resistance in FLT3-ITD acute myeloid leukemia cell models

  2026cites this paper
• Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitus.

  2026cites this paper
• An induced pluripotent stem cell-based chemical genetic approach for studying spinal muscular atrophy.

  2026cites this paper
• Biomarker discovery and drug repurposing in hepatocellular carcinoma through transcriptomics, machine learning, network pharmacology, and molecular dynamics.

  2026cites this paper
• In silico transcriptome-based drug screening identifies celastrol as a multi-species therapeutic agent against aging-related sarcopenia and mitochondrial dysfunction.

  2026cites this paper
• Multidimensional transcriptome dataset for systematic evaluation of Jakyakgamcho-tang-induced cell signatures.

  2026cites this paper
• DeepICER: A deep learning framework for predicting compound-induced gene expression profiles

  2026cites this paper
• Harnessing AI to fuse phenotypic signatures for drug target identification: progress in computational modeling

  2026cites this paper
• Network-based approach identifies key genes associated with tumor heterogeneity in HPV positive and negative head and neck cancer patients

  2025cites this paper
• From matrix factorization to graph neural networks: Advances in computational drug repositioning.

  2025cites this paper
• Combinatorial prediction of therapeutic perturbations using causally inspired neural networks.

  2025cites this paper
• Integrative Analysis of Mitochondrial‐Related Genes Reveals Diagnostic Biomarkers and Therapeutic Targets in Acute Pancreatitis

  2025cites this paper
• AI-enabled drug prediction and gene network analysis reveal therapeutic use of vorinostat for Rett Syndrome in preclinical models

  2025cites this paper
• SciLinker: a large-scale text mining framework for mapping associations among biological entities

  2025cites this paper
• Fine-Grained Cross-Attention Between Drug Structures and Genes for Perturbation Prediction

  2025cites this paper
• Cancer Reversion Therapy: Prospects, Progress and Future Directions

  2025cites this paper
• Transcriptome-wide Mendelian randomization and single-cell analysis during CD4+ T cell activation deciphers immunotherapeutic targets for colorectal cancer

  2025cites this paper
• Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis

  2025cites this paper
• Protein interactions, network pharmacology, and machine learning work together to predict genes linked to mitochondrial dysfunction in hypertrophic cardiomyopathy

  2025cites this paper
• Characterization of key genes and immune cell infiltration associated with endometriosis through integrating bioinformatics and experimental analyses

  2025cites this paper
• From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases

  2025cites this paper
• Machine learning integration of single-cell and bulk transcriptomics identifies fibroblast-driven prognostic markers in colorectal cancer

  2025cites this paper
• Conducting the Molecular Symphony: Network-Based Approaches to Substance Use Disorders.

  2025cites this paper
• Identification of new candidate drugs in myelodysplastic syndromes with splicing factor mutations by transcriptional profiling and connectivity map analysis

  2025cites this paper
• Multi-omics analysis reveals aspirin is associated with reduced risk of Alzheimer's disease

  2025cites this paper
• Transcriptomic Profile of Isocitrate Dehydrogenase Mutant Type of Lower-Grade Glioma Reveals Molecular Changes for Prognosis

  2025cites this paper
• Synthesis and discovery of guaianolide - eudesmanolide heterodimers as CDK2 inhibitors for the treatment of hepatocellular carcinoma.

  2025cites this paper
• Integrative transcriptome-based drug repurposing in tuberculosis

  2025cites this paper
• Integration of Single Cell and Bulk RNA-Sequencing Reveals Key Genes and Immune Cell Infiltration to Construct a Predictive Model and Identify Drug Targets in Endometriosis

  2025cites this paper
• In Silico Analysis Predicts Mutational Consequences of CITED2, NUDT4, and Ar18B in Patients with Bipolar Disorder.

  2024cites this paper
• Computational pipeline predicting cell death suppressors as targets for cancer therapy

  2024cites this paper
• GZMhi Cytotoxic T Cells: A Key Discovery in Fibrotic Hypersensitivity Pneumonitis

  2024cites this paper
• Integrative transcriptomic analysis identifies emetine as a promising candidate for overcoming acquired resistance to ALK inhibitors in lung cancer

  2024cites this paper
• Spatial resolved transcriptomics: Computational insights into gene transcription across tissue and organ architecture in diverse applications

  2024cites this paper
• Repositioning of drugs for the treatment of major depressive disorder based on prediction of drug-induced gene expression changes.

  2024cites this paper
• Exploration of a miRNA-mRNA network shared between acute pancreatitis and Epstein-Barr virus infection by integrated bioinformatics analysis

  2024cites this paper
• Unraveling new avenues in pancreatic cancer treatment: A comprehensive exploration of drug repurposing using transcriptomic data

  2024cites this paper
• Herb-CMap: a multimodal fusion framework for deciphering the mechanisms of action in traditional Chinese medicine using Suhuang antitussive capsule as a case study

  2024cites this paper
• Gene Therapy in the Light of Lifestyle Diseases: Budesonide, Acetaminophen and Simvastatin Modulates rAAV Transduction Efficiency

  2024cites this paper
• Application of GWAS summary data and drug-induced gene expression profiles of neural progenitor cells in psychiatric drug prioritization analysis

  2024cites this paper
• A Novel Pyrazole Exhibits Potent Anticancer Cytotoxicity via Apoptosis, Cell Cycle Arrest, and the Inhibition of Tubulin Polymerization in Triple-Negative Breast Cancer Cells

  2024cites this paper
• DrugSK: A Stacked Ensemble Learning Framework for Predicting Drug Combinations of Multiple Diseases

  2024cites this paper
• Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease

  2024cites this paper
• Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties

  2024cites this paper
• Cancer pharmacoinformatics: Databases and analytical tools

  2024cites this paper
• Analysis of transcription profiles for the identification of master regulators as the key players in glioblastoma

  2024cites this paper
• Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database.

  2024cites this paper
• CDCM: a correlation-dependent connectivity map approach to rapidly screen drugs during outbreaks of infectious diseases

  2024cites this paper
• Decoding cardiovascular risks: analyzing type 2 diabetes mellitus and ASCVD gene expression

  2024cites this paper
• Immune Gene Networks from Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

  2024cites this paper
• Exploring novel therapeutic opportunities for hypertension: a paradigm-shifting approach via integrative multiomic analysis, pioneering the path to precision medicine.

  2024cites this paper
• Identification of co-expressed central genes and transcription factors in acute myocardial infarction and diabetic nephropathy

  2024cites this paper
• Nutrient-Epigenome interactions: Implications for personalized nutrition against aging-associated diseases.

  2024cites this paper
• Network-based drug repurposing for schizophrenia

  2024cites this paper
• Lansoprazole Ameliorates Isoniazid-Induced Liver Injury.

  2024cites this paper
• Melasolv™: a potential preventive and depigmenting agent for the senescence of melanocytes

  2024cites this paper
• Drug Mechanism: A bioinformatic update.

  2024cites this paper
• Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorder.

  2024cites this paper
• DIGEP‐Pred 2.0: A web application for predicting drug‐induced cell signaling and gene expression changes

  2024cites this paper
• Optimizing in silico drug discovery: simulation of connected differential expression signatures and applications to benchmarking

  2024cites this paper
• Molecular mechanisms and diagnostic model of glioma-related epilepsy

  2024cites this paper
• Augmenting Predictive Accuracy in Pharmacological Mechanism of Action Models

  2024cites this paper
• Combinatorial prediction of therapeutic perturbations using causally-inspired neural networks

  2024cites this paper
• Finding new analgesics: Computational pharmacology faces drug discovery challenges.

  2024cites this paper
• Multiplexed Target Profiling with Integrated Chemical Genomics and Chemical Proteomics.

  2024cites this paper
• A study on the role of Taxifolin in inducing apoptosis of pancreatic cancer cells: screening results using weighted gene co-expression network analysis

  2024cites this paper
• DeepdlncUD: Predicting regulation types of small molecule inhibitors on modulating lncRNA expression by deep learning

  2023cites this paper
• Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids

  2023cites this paper
• Deep Learning Strategies For Rare Drug Mechanism of Action Prediction

  2023cites this paper
• Informatics on Drug Repurposing for Breast Cancer

  2023cites this paper
• Small molecule-mediated targeting of microRNAs for drug discovery: Experiments, computational techniques, and disease implications

  2023cites this paper
• Non-cell-autonomous cancer progression from chromosomal instability

  2023cites this paper
• Identification of genetic mechanisms underlying lipid metabolism-mediated tumor immunity in head and neck squamous cell carcinoma

  2023cites this paper
• Decoding Connectivity Map-based drug repurposing for oncotherapy

  2023cites this paper
• Knowledge Mapping of Drug Repositioning’s Theme and Development

  2023cites this paper
• Co‐expression pattern of SLC transporter genes associated with the immune landscape and clinical outcomes in gastric cancer

  2023cites this paper
• Approaches for sRNA Analysis of Human RNA-Seq Data: Comparison, Benchmarking

  2023cites this paper
• Src-Family B Kinase Inhibition Promotes Lung Endothelial Dysfunction and Guides Drug Discovery

  2023cites this paper
• Application of perturbation gene expression profiles in drug discovery—From mechanism of action to quantitative modelling

  2023cites this paper
• Bioinformatics and Connectivity Map Analysis Suggest Viral Infection as a Critical Causative Factor of Hashimoto’s Thyroiditis

  2023cites this paper
• Specific gene module pair-based target identification and drug discovery

  2023cites this paper
• Telomere-related genes as potential biomarkers to predict endometriosis and immune response: Development of a machine learning-based risk model

  2023cites this paper
• Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence

  2023cites this paper
• Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications

  2023cites this paper
• Genomics-based tools for drug discovery and development: From network maps to efficacy prediction

  2023cites this paper
• Identifying candidate drugs based on transcriptional landscape associated with triple-negative breast cancer

  2023cites this paper
• An AI Approach to Identifying Novel Therapeutics for Rheumatoid Arthritis

  2023cites this paper
• Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Kidney Cancers

  2023cites this paper
• Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathway

  2023cites this paper
• A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer

  2022cites this paper
• Combining multiomics and drug perturbation profiles to identify Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy muscle-specific treatments for spinal muscular atrophy Let us know how access to this document benefits you.

  2022cites this paper
• Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery

  2022cites this paper
• Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in In Vitro, In Vivo and Ex Vivo Models of Pulmonary Fibrosis

  2022cites this paper
• From pharmacogenetics to pharmaco-omics: Milestones and future directions

  2022cites this paper
• Integrating 3D genomic and epigenomic data to enhance target gene discovery and drug repurposing in transcriptome-wide association studies

  2022cites this paper
• Deficiency of autism-related Scn2a gene in mice disrupts sleep patterns and circadian rhythms.

  2022cites this paper
• In silico Drug Screening Approach Using L1000-Based Connectivity Map and Its Application to COVID-19

  2022cites this paper
• Single cell study of cellular diversity and mutual communication in chronic heart failure and drug repositioning.

  2022cites this paper
• Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency

  2022cites this paper